OMDA Form 144: 2,083 shares proposed sale

OMDA reported a proposed disposition of 2,083 shares of Common Stock via exercise of stock options on 06/24/2026.

Rhea-AI Filing Summary

OMDA reported a proposed disposition of 2,083 shares of Common Stock via exercise of stock options on 06/24/2026. The filing lists $38,118.90 associated with the 2,083-share entry and shows 59,448,507 shares outstanding as of 06/24/2026 as context. The excerpt also lists prior 10b5-1 sales by Craig Gracey: 2,083 shares on 06/22/2026 for $37,494.00 and 6,894 shares on 06/12/2026 for $120,123.06.

Insights

Corporate Governance Analyst

Form 144 records proposed insider dispositions tied to option exercise and prior 10b5-1 sales.

The filing shows a proposed sale of 2,083 shares via exercise of stock options on 06/24/2026, with an associated amount of $38,118.90. It also lists two recent 10b5-1 transactions by Craig Gracey totaling 9, (0) — (see numeric breakdown below).

Cash treatment and exact counterparty details are stated as Cash for the option exercise; prior 10b5-1 entries show proceeds of $37,494.00 and $120,123.06. Future activity will depend on holder decisions and any standing trading plans.

Key Figures

Proposed shares disposed: 2,083 shares Amount listed with 2,083 entry: $38,118.90 Shares outstanding: 59,448,507 shares +2 more

5 metrics

Proposed shares disposed 2,083 shares exercise of stock options on <date>06/24/2026</date>

Amount listed with 2,083 entry $38,118.90 <date>06/24/2026</date> line item

Shares outstanding 59,448,507 shares as of <date>06/24/2026</date>

10b5-1 sale on 06/22/2026 2,083 shares proceeds <money>$37,494.00</money>

10b5-1 sale on 06/12/2026 6,894 shares proceeds <money>$120,123.06</money>

Key Terms

Form 144, 10b5-1, exercise of stock options

3 terms

Form 144 regulatory

"reported a proposed disposition of 2,083 shares via exercise of stock options"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

10b5-1 regulatory

"10b5-1 Sales for CRAIG GRACEY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

exercise of stock options financial

"Securities To Be Sold | Common | 06/24/2026 | Exercise of Stock Options"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does OMDA's Form 144 disclose about the June 24, 2026 transaction?

The Form 144 discloses a proposed disposition of 2,083 shares via exercise of stock options dated 06/24/2026, with an associated amount of $38,118.90 and cash listed as the consideration.

Did OMDA report any recent 10b5-1 sales in the filing?

Yes. The filing lists 10b5-1 sales by Craig Gracey: 2,083 shares on 06/22/2026 for $37,494.00 and 6,894 shares on 06/12/2026 for $120,123.06.

How many OMDA shares were outstanding according to the excerpt?

The excerpt reports 59,448,507 shares outstanding as of 06/24/2026. This number is presented as context within the filing excerpt and is bound to that date.

Was the June 24, 2026 disposition executed for cash or shares?

The June 24, 2026 line shows the exercise of stock options with the consideration listed as Cash, indicating cash was the form of consideration for that reported entry.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/24/2026 - 04:39 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002021724
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Omada Health, Inc.
SEC File Number	001-42679
Address of Issuer	611 Gateway Blvd, Suite 120 South San Francisco CALIFORNIA 94080
Phone	8889878337
Name of Person for Whose Account the Securities are To Be Sold	CRAIG GRACEY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2083	38118.90	59448507	06/24/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/24/2026	Exercise of Stock Options	Issuer			2083	06/24/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for CRAIG GRACEY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	06/22/2026	2083	37494.00
10b5-1 Sales for CRAIG GRACEY 611 Gateway Blvd, Suite 120 South San Francisco CA 94080	Common	06/12/2026	6894	120123.06

144: Remarks and Signature

Remarks
Date of Notice	06/24/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/13/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Craig Gracey
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)